• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床预测因子与侵袭性/致残性疾病:溃疡性结肠炎和克罗恩病。

Clinical predictors of aggressive/disabling disease: ulcerative colitis and crohn disease.

机构信息

Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA 19104-4283, USA.

出版信息

Gastroenterol Clin North Am. 2012 Jun;41(2):443-62. doi: 10.1016/j.gtc.2012.01.008.

DOI:10.1016/j.gtc.2012.01.008
PMID:22500528
Abstract

Many clinical factors predict the aggressive course of CD. Younger age at initial diagnosis, the presence of perianal lesions, ileal involvement, smoking, and the need for therapy with corticosteroids are the major predictors of disabling disease or change of behavior to a more aggressive disease. On the other hand, treatment with azathioprine and biologic agents and colonic localization of disease are the major factors that are predictive of less aggressive CD course. The problem we face with determining the factors that increase the risk of disabling disease is that there is no standardized and consistent definition of disabling or aggressive disease. Only two studies analyzed predictors using the same definition of aggressive disease. Only Beaugerie and colleagues developed the score predictive of disabling disease based on three independent factors associated with disabling course that were present at the time of initial diagnosis of CD (requirement of corticosteroids, age less than 40 years, and presence of perianal disease). This score ranged from 0 to 3 points based on the presence of given parameters. The positive predictive value was 0.91 and 0.93 in patients having two or three risk factors, 0.61 for no factors present, and 0.67 for one factor present. In order to determine factors predictive of disabling CD there is a need to establish consistent definition of disabling disease with subsequent future studies on large group of patients to validate such definition and determine factors that may predict the aggressive course.

摘要

许多临床因素可预测 CD 的侵袭性病程。初诊时年龄较小、存在肛周病变、回肠受累、吸烟以及需要皮质类固醇治疗是发生致残性疾病或疾病行为向更具侵袭性转变的主要预测因素。另一方面,使用巯嘌呤和生物制剂治疗以及疾病位于结肠是 CD 病程侵袭性较低的主要预测因素。我们在确定增加致残性疾病风险的因素时面临的问题是,没有针对致残性或侵袭性疾病的标准化和一致定义。只有两项研究使用相同的侵袭性疾病定义分析了预测因素。只有 Beaugerie 及其同事基于与 CD 初诊时存在的致残病程相关的三个独立因素(需要皮质类固醇、年龄小于 40 岁和存在肛周疾病)制定了预测致残性疾病的评分。该评分基于给定参数的存在范围为 0 至 3 分。在存在两个或三个危险因素的患者中,阳性预测值分别为 0.91 和 0.93,无危险因素的患者为 0.61,存在一个危险因素的患者为 0.67。为了确定可预测致残性 CD 的因素,需要用随后针对大量患者的未来研究来确定致残性疾病的一致定义,并确定可能预测侵袭性病程的因素。

相似文献

1
Clinical predictors of aggressive/disabling disease: ulcerative colitis and crohn disease.临床预测因子与侵袭性/致残性疾病:溃疡性结肠炎和克罗恩病。
Gastroenterol Clin North Am. 2012 Jun;41(2):443-62. doi: 10.1016/j.gtc.2012.01.008.
2
Predictors of Crohn's disease.克罗恩病的预测因素。
Gastroenterology. 2006 Mar;130(3):650-6. doi: 10.1053/j.gastro.2005.12.019.
3
Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.诊断时的表型及其他潜在预后因素对炎症性肠病病程的影响。
Am J Gastroenterol. 2009 Feb;104(2):371-83. doi: 10.1038/ajg.2008.38. Epub 2009 Jan 27.
4
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.儿童及青年溃疡性结肠炎与克罗恩病的鉴别:北美儿科胃肠病学、肝病学和营养学会及美国克罗恩病和结肠炎基金会工作组报告
J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74. doi: 10.1097/MPG.0b013e31805563f3.
5
Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.早期使用硫唑嘌呤/生物制剂治疗与克罗恩病患者(无论是否吸烟)首次手术风险降低和手术时间延迟有关,但不增加再次手术风险,而吸烟则降低溃疡性结肠炎患者结肠切除术的风险。
Eur J Gastroenterol Hepatol. 2010 Jul;22(7):872-9. doi: 10.1097/MEG.0b013e32833036d9.
6
Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.炎症性肠病的黏膜愈合:来自挪威一项基于人群队列研究的结果
Gastroenterology. 2007 Aug;133(2):412-22. doi: 10.1053/j.gastro.2007.05.051. Epub 2007 Jun 2.
7
Relationship between smoking and colonic involvement in inflammatory bowel disease.吸烟与炎症性肠病结肠受累之间的关系。
Rev Esp Enferm Dig. 1998 Dec;90(12):833-40.
8
Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality.日本克罗恩病患者的临床病程及长期预后:预测因素、手术率和死亡率
J Gastroenterol. 2003;38(10):942-53. doi: 10.1007/s00535-003-1177-9.
9
Inflammatory bowel diseases: controversies in the use of diagnostic procedures.炎症性肠病:诊断程序使用中的争议
Dig Dis. 2009;27(3):269-77. doi: 10.1159/000228560. Epub 2009 Sep 24.
10
NOD2/CARD15: relevance in clinical practice.NOD2/CARD15:在临床实践中的相关性
Best Pract Res Clin Gastroenterol. 2004 Jun;18(3):569-75. doi: 10.1016/j.bpg.2003.12.008.

引用本文的文献

1
Targeted urinary metabolomics combined with machine learning to identify biomarkers related to central carbon metabolism for IBD.靶向尿液代谢组学结合机器学习以识别与炎症性肠病中心碳代谢相关的生物标志物。
Front Mol Biosci. 2025 Aug 11;12:1615047. doi: 10.3389/fmolb.2025.1615047. eCollection 2025.
2
Magnetic resonance enterography to predict subsequent disabling Crohn's disease in newly diagnosed patients (METRIC-EF)-multivariable prediction model, multicentre diagnostic inception cohort.磁共振小肠造影预测新诊断患者中后续致残性克罗恩病(METRIC-EF)-多变量预测模型,多中心诊断性起始队列研究
Eur Radiol. 2025 May 14. doi: 10.1007/s00330-025-11636-8.
3
Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB.
基于 GEDIIB 两年的全国登记数据,巴西炎症性肠病患者严重程度相关的临床因素。
Sci Rep. 2024 Feb 21;14(1):4314. doi: 10.1038/s41598-024-54332-1.
4
Development and validation of a nomogram to predict indolent course in patients with ulcerative colitis: a single-center retrospective study.预测溃疡性结肠炎患者惰性病程的列线图的开发与验证:一项单中心回顾性研究
Gastroenterol Rep (Oxf). 2022 Jun 30;10:goac029. doi: 10.1093/gastro/goac029. eCollection 2022.
5
Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.抗纤维化治疗在狭窄型克罗恩病中的发展:其他纤维化疾病随机试验的经验教训。
Physiol Rev. 2022 Apr 1;102(2):605-652. doi: 10.1152/physrev.00005.2021. Epub 2021 Sep 27.
6
Are Steroids Still Useful in Immunosuppressed Patients With Inflammatory Bowel Disease? A Retrospective, Population-Based Study.类固醇在免疫抑制的炎症性肠病患者中仍有用吗?一项基于人群的回顾性研究。
Front Med (Lausanne). 2021 Jun 25;8:651685. doi: 10.3389/fmed.2021.651685. eCollection 2021.
7
Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic review.预测生物标志物识别可能发展为严重克罗恩病的患者:系统评价。
Health Technol Assess. 2021 Jul;25(45):1-66. doi: 10.3310/hta25450.
8
Medical therapies for postoperative Crohn's disease.克罗恩病术后的医学治疗方法。
Therap Adv Gastroenterol. 2021 Feb 15;14:1756284821993581. doi: 10.1177/1756284821993581. eCollection 2021.
9
Prophylaxis of Crohn's disease recurrence: A surgeon's perspective.克罗恩病复发的预防:外科医生的观点
Ann Gastroenterol Surg. 2020 Jun 24;4(5):514-520. doi: 10.1002/ags3.12368. eCollection 2020 Sep.
10
Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study.溃疡性结肠炎相关结直肠癌的危险因素:一项回顾性队列研究。
Medicine (Baltimore). 2020 Aug 7;99(32):e21686. doi: 10.1097/MD.0000000000021686.